Jump to: site navigation, content.

Local stuff that matters to you.
News & events for
Friday, November
27

Monday, May 5, 2008 , Updated

Dallas-based Access Pharmaceuticals featured in investment book

0

Access Pharmaceuticals announced today that renowned business columnist and author Gene Marcial of BusinessWeek has highlighted Access Pharmaceuticals in his recently released investing book titled "7 Commandments of Stock Investing." In a section pertaining to his sixth commandment of "not fearing the unknown," Mr. Marcial includes Access Pharmaceuticals as one of three "unrecognized attractive biotechs" that are not widely followed by Wall Street but "whose prospects look tantalizing because of their huge potential value." Included in the analysis is commentary on Access' ProLindac, its proprietary second-generation DACH platinum drug that is being developed to target the markets currently being served by Sanofi-Aventis' Eloxatin, and on MuGard, Access' FDA-approved treatment for oral mucositis. Gene Marcial has been BusinessWeek's "Inside Wall Street" columnist for the past 26 years, and is a former columnist at the Wall Street Journal.

Source: Access Pharmaceuticals



What do you think?

:

:

Email Print Comment Tell us your story

See more stories in:


Quantcast